Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.65 +0.00 (+0.68%)
As of: Sep 30, 2026 · 3:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Capital Leases (2015 - 2017)

Updated

Biodexa Pharmaceuticals' Capital Leases was $38,502 in the quarter ended Dec 31, 2017, down 40.4% from $64,648 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Capital Leases (2015 - 2017) Analysis & Trends

As of Dec 31, 2017, Capital Leases at Biodexa Pharmaceuticals came in at $37,359, down 47.0% from the prior year.

  • In earlier years, Capital Leases was $70,544 in the year ended Dec 31, 2016 (-32.2%) and $103,980 in the year ended Dec 31, 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 38,502.28
Dec 31, 2016 64,647.56
Dec 31, 2015 103,189.36
API Access

Biodexa Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=BDRX&period=max&api_key=YOUR_API_KEY